Cargando…
Efficacy and Imaging-Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer
KRAS is one of the most commonly mutated oncogenes in lung, colorectal, and pancreatic cancers. Recent clinical trials directly targeting KRAS G12C presented encouraging results for a large population of non–small cell lung cancer (NSCLC), but resistance to treatment is a concern. Continued explorat...
Autores principales: | Lee, Catherine, Jiang, Ziyue Karen, Planken, Simon, Manzuk, Lisa K., Ortiz, Roberto, Hall, Michael, Noorbehesht, Kavon, Ram, Sripad, Affolter, Timothy, Troche, Gabriel E., Ihle, Nathan T., Johnson, Theodore, Ahn, Youngwook, Kraus, Manfred, Giddabasappa, Anand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320479/ https://www.ncbi.nlm.nih.gov/pubmed/37186518 http://dx.doi.org/10.1158/1535-7163.MCT-22-0810 |
Ejemplares similares
-
Targeting and pharmacology of an anti-IL13Rα2 antibody and antibody-drug conjugate in a melanoma xenograft model
por: Gupta, Parul, et al.
Publicado: (2021) -
Pharmacokinetic/Pharmacodynamic Analysis of Savolitinib plus Osimertinib in an EGFR Mutation–Positive, MET-Amplified Non–Small Cell Lung Cancer Model
por: Jones, Rhys D.O., et al.
Publicado: (2023) -
Mouse lung automated segmentation tool for quantifying lung tumors after micro-computed tomography
por: Montgomery, Mary Katherine, et al.
Publicado: (2021) -
Local Treatment of a Pediatric Osteosarcoma Model with a 4-1BBL Armed Oncolytic Adenovirus Results in an Antitumor Effect and Leads to Immune Memory
por: Martinez-Velez, Naiara, et al.
Publicado: (2022) -
Development of a High-throughput NanoBRET Screening Platform to Identify Modulators of the RAS/RAF Interaction
por: Durrant, David E., et al.
Publicado: (2021)